Skip to main content

MET Inhibitors: Small Molecules and Peptides

HGF receptor, a product of the proto-oncogene c-met, is a heterodimeric transmembrane glycoprotein that is a receptor-type tyrosine kinase. c-MET is synthesized as a single-chain precursor (pr170) which undergoes post-translational glycosylation and proteolytic cleavage to give rise to the heterodimeric mature form.

7 results for "MET Inhibitors Small Molecules and Peptides" in Products

7 results for "MET Inhibitors Small Molecules and Peptides" in Products

MET Inhibitors: Small Molecules and Peptides

HGF receptor, a product of the proto-oncogene c-met, is a heterodimeric transmembrane glycoprotein that is a receptor-type tyrosine kinase. c-MET is synthesized as a single-chain precursor (pr170) which undergoes post-translational glycosylation and proteolytic cleavage to give rise to the heterodimeric mature form.

Potent and selective MET inhibitor

Highly selective MET inhibitor

VEGFR inhibitor. Also inhibits KIT, RET, MET and FLT3

Potent c-MET/ALK inhibitor

Selective and potent c-MET kinase inhibitor

Protein kinase inhibitor

Potent VEGFR inhibitor; also inhibits other RTKs

Results Per Page
5 10 25 50
/ 1
Select 2 to 4 Items to Compare
 
 
 
 
×